Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Akoya Biosciences, Inc.AKYA-1.871.211.82-5.02-128.20%-21.12%43.61$2.32$5.566,722$2.28

Detail of Akoya Biosciences, Inc.

 
CEO
Mr. Brian McKelligon
Employees
330
Industry
Medical Instruments & Supplies
Sector
Healthcare
Market cap
$113M

Company details

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$93.22M
Cost of goods (CoG)
-$39.56M
Gross profit (GP)
$53.66M
Operating expense (OE)
-$97.56M
Research and development (R&D)
-$20.68M
General and administrative (G&A)
-$76.87M
Operating income (OI)
-$48.14M
Other income expense (OIE)
-$5.94M
Pretax income (PI)
-$60.25M
Tax (TAX)
-$103,000.00
Net income (NI)
-$60.35M
Akoya Biosciences, Inc.
AKYA • XNGS • US
$2.28
-2.53 (-52.60%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$1.22
Margin profit
-64.74%
52 week low
$1.92
52 week high
$6.06
50-day simple moving average
$2.28
200-day simple moving average
$2.32
Percent held by insiders
11.09%
Percent held by institutions
69.93%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
AKYA -48.65%
eps change
AKYA 0.00%